Transplantation Proceedings
Volume 35, Issue 3, Supplement , Pages S18-S24 , May 2003

The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation

  • J Camardo

      Affiliations

    • Wyeth Research, Collegeville, Pennsylvania, USA
    • Corresponding Author InformationAddress reprint requests to Joseph Camardo, Wyeth Research, 500 Arcola Rd, Collegeville, PA 19426, USA.

References 

  1. Sehgal SN, Vezina C: Some physical, chemical and biological properties of rapamycin AY-22989. Stability data and assay methods. Wyeth-Ayerst, data on file, 1973
  2. Morris RE. Transplant Rev. 1992;6:39
  3. Sehgal SN, Baker H, Vezina C. J Antibiot. 1975;28:727
  4. Baker H, Sidorowicz A, Sehgal SN, et al.  J Antibiot. 1978;31:539
  5. Martel RR, Kilcius J, Galet S. Can J Physiol Pharmacol. 1977;55:48
  6. Eng CP, Sehgal SN, Vezina C. J Antibiot. 1984;37:1231
  7. Douros J, Suffness M. Cancer Treat Rev. 1981;8:63
  8. Calne RY, Collier DS, Lim S, et al.  Lancet. 1989;2:227
  9. Morris RE, Meiser BM. I Med Sci Res. 1989;17:877
  10. Kahan BD, Chang JY, Sehgal SN. Transplantation. 1991;52:185
  11. Stepkowski SM, Chen H, Daloze P, et al.  Transplantation. 1991;51:232
  12. Sehgal SN: Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action: immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Wyeth-Ayerst, data on file, 1997
  13. Kunz J, Henriquez R, Schneider U, et al.  Cell. 1993;73:585
  14. Chiu MI, Katz H, Berlin V. Proc Natl Acad Sci USA. 1995;91:12574
  15. Chen J, Zheng XF, Brown EJ, et al.  Proc Natl Acad Sci USA. 1995;92:4947
  16. Choi J, Chen J, Schreiber SL, et al.  Science. 1996;273:239
  17. Nicolaou KC, Chakraborty TK, Piscopio AD, et al.  J Am Chem Soc. 1993;115:4419
  18. Van Buren C: Presented at the XVIII International Congress of the Transplantation Society, Chicago, May 13-17, 2000 (Abstract P0533)
  19. Murgia MG, Jordan S, Kahan BD. Kidney Int. 1996;49:209
  20. Zimmerman J, Kahan BD. J Clin Pharmacol. 1997;37:405
  21. Sehgal SN, Camardo JS, Scarola JA, et al.  Curr Opin Nephrol Hypertens. 1995;4:482
  22. Kahan BD. Transplantation. 1997;63:170
  23. Kahan BD, Gibbons S, Tejpal N, et al.  Transplantation. 1991;51:232
  24. Kahan BD, Julian BA, Pescovitz MD, et al.  Transplantation. 1999;68:1526
  25. Kahan BD  Rapamune US Study Group . Lancet. 2000;356:194
  26. MacDonald AS  Rapamune Global Study Group . Transplantation. 2001;71:271
  27. Brattstrom C, Wilczek H, Tyden G, et al.  Transplantation. 1998;65:1272
  28. Hoogeveen RC, Ballantyne CM, Pownall HJ, et al.  Transplantation. 2001;72:1244
  29. Groth CG, Backman L, Morales JM, et al.  Transplantation. 1999;67:1036
  30. Myers BD, Newton L, Oyer P. Transplant. 1992;23:41
  31. Gonwa T, Alveranga G, Ancona K, et al.  Transplantation. 2000;59(suppl):S360
  32. Johnson RWG, Kreis H, Oberbauer R, et al.  Transplantation. 2001;72:777
  33. Kahan BD, Camardo JS. Transplantation. 2001;72:1181
  34. Kahan BD. Expert Opin Pharmacother. 2001;2:1903
  35. Gregory CR, Billingham ME, Morris RE. Transplantation. 1993;55:1409
  36. Marx S, Jayaraman T, Go LO, et al.  Transplantation. 1995;59:390
  37. Walpoth BH, Pavlicek M, Celik B, et al.  Eur J Cardiothorac Surg. 2001;19:487
  38. Marx SO, Marks AR. Circulation. 2001;104:852
  39. Sousa JE, Costa MA, Abizaid A, et al.  Circulation. 2001;103:192

PII: S0041-1345(03)00356-7

doi: 10.1016/S0041-1345(03)00356-7

Transplantation Proceedings
Volume 35, Issue 3, Supplement , Pages S18-S24 , May 2003

Article Tools

* Image Usage & Resolution